Israel Biotech Fund
About
Israel Biotech Fund, Building the future of Israeli Biotech Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages. Our partners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.
Key facts
- Website
- israelbiotechfund.com
- Type
- Venture Capital
- Headquarters
- Israel
- Funds raised
- $212M
- Portfolio companies
- 7
- Stages
- Series ASeries BSeries G
- Cheque size
- $8M to $40M
- Sector focus
- Life SciencesHealthcareLungTreatmentBiotech
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 28 Jul 2025 | Cassidy Bio | Undisclosed round | $8M |
| 29 Oct 2024 | Vensica Medical | Undisclosed round | $11M |
| 30 Nov 2022 | Nectin Therapeutics | Series B | $25M |
| 13 May 2021 | SpliSense | Series B | $29M |
| 28 May 2019 | Ayala Pharmaceuticals | Series B | $30M |
| 11 Apr 2018 | Ayala Pharmaceuticals | Series A | $17M |
| 19 Jun 2017 | Gamida Cell | Series G | $40M |
Add first review
Frequently asked
What companies has Israel Biotech Fund invested in?
Israel Biotech Fund has invested in Cassidy Bio, Vensica Medical, Nectin Therapeutics, SpliSense, Ayala Pharmaceuticals and 2 more.
AUM
$212M
PORTFOLIO
7